Abstract | INTRODUCTION AND OBJECTIVES: PATIENTS AND METHODS: From July 1998 to July 1999, 206 patients (62 +/- 5 years) underwent implantation of 231 Tenax stents in 9 centers as the only revascularization procedure. The most frequent clinical indication was unstable angina (66%), and most of the lesions were complex (class B2 and C). The target vessels were the left anterior descending (51%) and right coronary arteries (36%). The ejection fraction was < 0.5 in 19% cases. RESULTS: Revascularization was complete in 70%, elective in 80%, and the implantation was direct in 25% of the cases. The procedure was successful in all the lesions, reducing stenosis from 62 +/- 16 to 16 +/- 10% and increasing the minimal luminal diameter from 0.81 +/- 0.40 to 2.61 +/- 0.59 mm. The TIMI flow was reduced in 30%, but normalized after the stent in all but one case. The incidence of cardiac events was minimal: 1 acute thrombosis (0.5%) resolved by a new angioplasty and 1 non-Q myocardial infarction (0.5%). At the 6-month clinical follow-up 10% of the patients presented complaints of angina greater than class II, and a new angioplasty was carried out in 1.9% of these cases. CONCLUSION: Clinical and angiographic data suggest that the hydrogenated silicon carbide coating of the Tenax coronary stent may indeed play a beneficial role in patient outcome, and should therefore be evaluated by prospective clinical trials.
|
Authors | J A Fournier, J Calabuig, A Merchán, J M Augé, R Melgares, T Colman, R Martín De Dios, L Insag, I Santos |
Journal | Revista espanola de cardiologia
(Rev Esp Cardiol)
Vol. 54
Issue 5
Pg. 567-72
(May 2001)
ISSN: 0300-8932 [Print] Spain |
Vernacular Title | Resultados iniciales y seguimiento clínico a 6 meses tras el implante de un stent coronario recubierto de carburo de silicio. |
PMID | 11412747
(Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biocompatible Materials
- Carbon Compounds, Inorganic
- Silicon Compounds
- silicon carbide
|
Topics |
- Angina, Unstable
(therapy)
- Biocompatible Materials
- Carbon Compounds, Inorganic
- Coronary Disease
(complications, surgery)
- Follow-Up Studies
- Humans
- Myocardial Revascularization
- Prosthesis Implantation
- Registries
- Silicon Compounds
- Stents
(adverse effects)
- Treatment Outcome
|